Key Events This Week
09 Feb: Stock rallies 3.57% to Rs.336.45, outpacing Sensex
10 Feb: Technical momentum shifts amid mixed indicator signals
13 Feb: Death Cross forms, signalling bearish trend ahead
13 Feb: Technical downshift amid price momentum decline
09 February 2026: Strong Opening Rally Outpaces Sensex
Gujarat Themis Biosyn Ltd began the week on a positive note, surging 3.57% to close at Rs.336.45 on 09 Feb 2026. This gain notably outperformed the Sensex, which rose 1.04% to 37,113.23. The stock’s volume of 2,977 shares indicated solid investor interest. This rally reflected a short-term recovery attempt following prior volatility, with the stock trading comfortably above its 52-week low of Rs.192.35 but still well below its 52-week high of Rs.479.45.
10 February 2026: Mixed Technical Momentum Signals Emerging
On 10 Feb, the stock continued to advance modestly by 0.79% to Rs.339.10, again outperforming the Sensex’s 0.25% gain. However, technical analysis revealed a complex picture. Daily moving averages turned mildly bullish, suggesting some short-term strength, but weekly and monthly indicators such as MACD and Bollinger Bands remained bearish or neutral. The stock’s technical momentum shifted from mildly bearish to sideways, indicating indecision among investors. Despite the short-term gains, caution was advised due to mixed signals across timeframes.
Just made the cut! This Mid Cap from the Heavy Electrical Equipment sector entered our elite Top 1% list recently. Discover it before the crowd catches on!
- - Top-rated across platform
- - Strong price momentum
- - Near-term growth potential
11 February 2026: Profit Taking Triggers Decline Despite Sensex Gains
The stock reversed course on 11 Feb, falling 1.99% to Rs.332.35, while the Sensex inched up 0.13% to 37,256.72. The decline reflected profit-taking amid the mixed technical backdrop. Volume dropped to 2,131 shares, indicating reduced buying interest. This day marked the beginning of a short-term downtrend, with the stock retreating from its recent highs and signalling growing investor caution.
12 February 2026: Sharp Decline Amid Negative Market Sentiment
On 12 Feb, Gujarat Themis Biosyn Ltd experienced a sharper fall of 3.79%, closing at Rs.319.75, underperforming the Sensex which declined 0.56%. The stock’s volume surged to 3,681 shares, suggesting increased selling pressure. Technical indicators such as weekly MACD and Bollinger Bands remained bearish, reinforcing the negative momentum. This decline underscored the stock’s vulnerability to broader market weakness and sector-specific headwinds.
13 February 2026: Death Cross Formation and Technical Downshift Confirm Bearish Outlook
The week ended on a cautious note as the stock fell another 2.03% to Rs.313.25 on 13 Feb, while the Sensex dropped 1.40% to 36,532.48. Most notably, Gujarat Themis Biosyn Ltd formed a Death Cross, where the 50-day moving average crossed below the 200-day moving average, a classic bearish signal indicating potential sustained downward pressure. This technical event was accompanied by a shift from sideways to mildly bearish momentum, with key indicators such as MACD, Bollinger Bands, and KST oscillator signalling weakening price strength.
Despite daily moving averages showing mild bullishness, the overall technical landscape suggested caution. The stock’s Mojo Score stood at 42.0, categorised as a Sell rating, reflecting deteriorating momentum and a downgrade from Hold earlier in January. Elevated valuation metrics, including a P/E ratio of 73.00, further complicated the outlook amid the bearish technical signals.
Why settle for Gujarat Themis Biosyn Ltd? SwitchER evaluates this small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Weekly Price Performance: Gujarat Themis Biosyn Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-09 | Rs.336.45 | +3.57% | 37,113.23 | +1.04% |
| 2026-02-10 | Rs.339.10 | +0.79% | 37,207.34 | +0.25% |
| 2026-02-11 | Rs.332.35 | -1.99% | 37,256.72 | +0.13% |
| 2026-02-12 | Rs.319.75 | -3.79% | 37,049.40 | -0.56% |
| 2026-02-13 | Rs.313.25 | -2.03% | 36,532.48 | -1.40% |
Key Takeaways
Positive Signals: The stock showed early-week strength with a 3.57% gain on 09 Feb, outperforming the Sensex. Daily moving averages turned mildly bullish midweek, suggesting some short-term buying interest. Long-term returns remain impressive, with 5-year gains exceeding 900% and a decade-long surge over 5,000%, underscoring the company’s historical growth trajectory.
Cautionary Signals: The formation of a Death Cross on 13 Feb is a significant bearish technical event, signalling potential sustained downward momentum. Mixed technical indicators throughout the week, including bearish MACD and Bollinger Bands on weekly and monthly charts, highlight weakening momentum. The stock’s Mojo Score downgrade to Sell and elevated P/E ratio of 73.00 relative to the industry average of 32.68 further suggest valuation and momentum risks. The stock underperformed the Sensex by 3.03% over the week, reflecting growing investor caution.
Conclusion
Gujarat Themis Biosyn Ltd’s week was marked by a transition from short-term bullish attempts to a more cautious and bearish technical stance. While early gains outpaced the broader market, the emergence of the Death Cross and a series of bearish momentum indicators signal a potential shift towards a prolonged downtrend or consolidation phase. The stock’s elevated valuation and recent downgrade to a Sell rating reinforce the need for prudence. Investors should closely monitor technical developments and volume trends for signs of stabilisation or further weakness amid sector-specific challenges.
Unlock special upgrade rates for a limited period. Start Saving Now →
